
Cat. #162225
Mutu Human EBV-related BL Cell Line
Cat. #: 162225
Organism: Human
Tissue: Blood
Model: Tumour Cell Line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Alan Bernard Rickinson
Institute: University of Birmingham
Primary Citation: Gregory CD et al. 1988. J Exp Med. Jun 1, 167(6), 1811-1824. PMID: 2898508
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Mutu Human EBV-related BL Cell Line
- Cancer type: Blood cancer
- Cancers detailed: Burkitt's lymphoma
- Organism: Human
- Gender: Male
- Tissue: Blood
- Model: Tumour Cell Line
- Model description: EBV genome-positive
- Conditional: No
- Description: BL lines were established from EBV genome-positive BL biopsy samples.
Handling
- Format: Frozen
- Shipping conditions: Dry Ice
- Storage conditions: Liquid Nitrogen
References
- Gregory CD et al. 1990. J Gen Virol. Jul, 7, 1481-96. PMID: 2165133
- Gregory CD et al. 1988. J Exp Med. Jun 1, 167(6), 1811-1824. PMID: 2898508
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)

